Search

Displaying results 9951 - 9960 of 10000 in total
  1. Drug

    FAV-201

    go.drugbank.com/drugs/DB06130
    Experimental

    FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.

  2. Drug

    Dersalazine

    go.drugbank.com/drugs/DB06251
    Investigational

  3. Drug

    Otilimab

    go.drugbank.com/drugs/DB06303
    Investigational

    Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).

  4. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

  5. Drug

    MC-1

    go.drugbank.com/drugs/DB05315
    Experimental

    Medicure's MC-1 drug is a cardio-protectant, designed to reduce the damage to the heart when arteries are blocked and when they are subsequently reopened after bypass surgery.

  6. Drug

    Valtorcitabine

    go.drugbank.com/drugs/DB06187
    Investigational

  7. Drug

    Celgosivir

    go.drugbank.com/drugs/DB06580
    Investigational

  8. Drug

    BMN-351

    go.drugbank.com/drugs/DB18186
    Investigational

    BMN-351 is a fully modified 18-mer oligonucleotide with a TEG modification at its 5' end that binds to exon 51 of dystrophin pre-mRNA.

  9. Drug

    SNS01-T

    go.drugbank.com/drugs/DB17302
    Investigational

    It is composed of three components: a B cell-specific plasmid expressing eIF5AK50R; an siRNA that targets the native eIF5A that promotes growth/anti-apoptosis of cancer cells; and polyethylenimine.

  10. Drug

    Evifacotrep

    go.drugbank.com/drugs/DB21510
    Investigational

    The usage of the INN stem '-cotrep' in the name indicates that Evifacotrep is a transient receptor potential canonical channel 5 (TRPC5) antagonist.